API

Backed by our strong R&D team and state-of-the-art facilities, we, at Raghav Life Science, have developed commercially viable processes for generic APIs and intermediates for our global partners. We offer high-quality generic drugs at competitive costs by integrating our experience, skills, and technology-driven operations.

To reach high standards of operational efficiency and consistent production, our manufacturing processes are built around quality control and assurance, supply chain management, regulatory and project management.

Our manufacturing facilities are designed to handle a wide range of complex chemistries and operating conditions allowing our partners to convert their concepts to bulk drug API production.

  • api-icon-1

    Competitive global prices with quality and consistent production.

  • api-icon-2

    Globally recognized, WHO GMP certified manufacturing plant

  • iso-icon

    ISO 9001:2015 Certified for R&D Lab

  • api-icon-3

    Reliable customer support through knowledge transfer and documentation support.

APIList

We at Raghava Life Science discover solutions that reduce costs and increase speed to market. If you have questions, our experienced R&D team is ready to talk with you to help you accelerate your most pressing commercial API manufacturing project.

API NameCAS NumberSpecificationsTherapeutic CategoryStatus
Lacosamide175481-36-4EP/USPAnticonvulsantCommercialised. DMF is available
Favipiravir259793-96-9In-house (ICH)AntiviralCommercialised. DMF is available
Bilastine202189-78-4In-house (ICH)AntihistamineCommercialized. DMF is available
Levetiracetam102767-28-2USP/EP/IPAnticonvulsantCommercialized. ODMF work is in progress
Vildagliptin274901-16-5In-house (ICH)AntidiabeticCommercialized. ODMF work is in progress
Linagliptin668270-12-0In-house (ICH)Antidiabetic Commercialized. ODMF work is in progress
Rivaroxaban366789-02-8In-house (ICH)AnticoagulantCommercialized. ODMF work is in progress

APIsUNDER DEVELOPMENT

We have been working on developing new molecules and expanding our portfolio.
For an updated list, please feel free to reach out to us.
Email - marketing@raghavalife.com

API NameCAS NumberSpecificationsTherapeutic CategoryStatus
Empagliflozin864070-44-0In-house (ICH)AntidiabeticOptimisation under progress
Dapagliflozin960404-48-2In-house (ICH)AntidiabeticOptimisation under progress
Sitagliptin486460-32-6In-house (ICH)AntidiabeticUnder development
Apixaban503612-47-3In-house (ICH)AnticoagulantOptimisation under progress
Amlodipine Besylate88150-42-9In-house (ICH)AntihypertensionOptimisation under progress
Ibuprofen15687-27-1In-house (ICH)NSAIDOptimisation under progress
Telmisartan144701-48-4In-house (ICH)AntihypertensionUnder development
Losartan114798-26-4In-house (ICH)AntihypertensionUnder development
Oseltamivir196618-13-0In-house (ICH)AntiviralUnder development
CONTACT US

Fully dedicated
in your service.

To reach high standards of operational efficiency and consistent production, our manufacturing processes are built around quality control and assurance, supply chain management, regulatory and project management.

    GEt in touch